Xcout Intel
EXUMA Biotech Corp. competitors & alternatives
The 12 closest competitors and alternatives to EXUMA Biotech Corp. — ranked by similarity to what EXUMA Biotech Corp. actually does, not by market-cap band.
Subscribe to see EXUMA Biotech Corp.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About EXUMA Biotech Corp.
EXUMA Biotech Corp. is a clinical-stage biotechnology company headquartered in West Palm Beach, Florida, focused on discovering and developing innovative cell therapies and oncology treatments.
EXUMA Biotech Corp. at a glance
EXUMA Biotech Corp. is a company headquartered in United States. Its most recent funding round raised $70M in May 2026. Xcout tracks 6 named people at EXUMA Biotech Corp., including Gregory Frost (Executive Officer).
EXUMA Biotech Corp. leadership
- Gregory FrostExecutive Officer
- Richard YanExecutive Officer
- Daniel FlynnDirector
- David RamsayDirector
- Frank McCormickDirector
- Houston HolmesDirector
EXUMA Biotech Corp. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $70M | — | |
| Series B | $19M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 EXUMA Biotech Corp. competitors
Ranked by semantic similarity — how close each company is to EXUMA Biotech Corp. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Eureka Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing transformative technology platforms and first-in-class T-cell therapies to access cancer-specific targets.
Close match by what they do
Kaida BioPharma Inc. is a biotechnology company operating in the deep-tech therapeutic R&D sector with a corporate office located in Fort Lauderdale, Florida.
Biotech
Bellicum Pharmaceuticals, Inc. is a company focused on engineering high-performance cellular immunotherapies. These therapies are developed to combat diseases.
Biotech
ImmPACT Bio USA, Inc. is a clinical-stage biotechnology company headquartered in West Hills, California. The company focuses on developing advanced cell therapies and immunotherapies to treat cancer and other serious diseases.
Biotechnology
Arcellx, Inc. is a clinical-stage biotechnology company headquartered in Gaithersburg, Maryland, dedicated to developing innovative immunotherapies and cell therapies for cancer patients.
Biotechnology
Aegle Therapeutics Corp. is a clinical-stage biotechnology company headquartered in Miami, Florida, with additional operations in Woburn, Massachusetts. The company is a leader in developing novel extracellular vesicle therapies to treat various diseases and disorders.
Close match by what they do
RegenX Science Inc. is a research-focused organization performing genomic analyses to map gene expression profiles relevant to wound healing and tissue regeneration, with its corporate office located in West Palm Beach, Florida.
Close match by what they do
Marizyme, Inc. is a publicly traded biotechnology company incorporated in 2007 and headquartered in Jupiter, Florida. The company focuses on drug pipelines, patents, and clinical trials within the biotech sector.
Close match by what they do
Immune Therapeutics, Inc. is a late-stage biotechnology company with corporate executive office locations in Florida, focusing on the development of immune-regulation therapies.
Close match by what they do
ImmPACT Bio USA, Inc. is a clinical-stage company headquartered in West Hills, California, dedicated to developing novel cell therapies.
Close match by what they do
eXIthera Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company founded in 2012, focused on developing novel therapeutics and drug pipelines in specialized medical areas.
Close match by what they do
Incysus Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in New York, United States. The company focuses on delivering novel cell therapies using genetically modified cells for the treatment of cancer.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of EXUMA Biotech Corp. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for EXUMA Biotech Corp.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →